Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

New clues link Long COVID and POTS

18

Sep 2026

New clues link Long COVID and POTS

Dizziness, fatigue, brain fog and a racing heart. They’re commonly associated with Long COVID, but new Adelaide University research suggests that for some people, these symptoms may also be indications of Postural orthostatic tachycardia syndrome (POTS), a debilitating and difficult-to-diagnose condition.

Breast density clue for cancer risk

18

Sep 2026

Breast density clue for cancer risk

Women with a higher Body Mass Index in early adulthood may have a lower risk of developing breast cancer after the menopause because of lasting changes in the structure of their breast tissue, according to researchers at The University of Manchester and Manchester University NHS Foundation Trust.

Transplanted human cortical organoids filled most of a mouse cortex. Then they began to connect

18

Sep 2026

Transplanted human cortical organoids filled most of a mouse cortex. Then they began to connect

Researchers created xenocortical mice by transplanting human cortical organoids into animals genetically depleted of much of their native cortex, allowing the human tissue to occupy most of the available cortical space and form anatomical connections throughout the host nervous system. The grafts developed diverse cortical cell types, including L5-ET and VEN-like neurons, generated organized neural activity, and produced measurable cellular and behavioral responses to hypoxic injury.

Some food manufacturers could capture major nutrition and environmental gains by changing surprisingly few products

18

Sep 2026

Some food manufacturers could capture major nutrition and environmental gains by changing surprisingly few products

Researchers assessed the nutritional quality and environmental impacts of product portfolios from 44 major UK food and beverage manufacturers, covering 51.5% of the retail market. Their modelling showed that targeted changes to existing product lines could capture a substantial share of the potential nutrition and environmental gains for some manufacturers, although broader food-system changes would still be required to meet national and societal targets.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.